Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prochymal in acute myocardial infarction
NCT00877903Phase 2Completed
- Sponsor
- Mesoblast Ltd
- Start
- Mar 2009
- Primary completion
- May 2011
- Modality
- Stem Cell Therapies
- Countries
- 2
01
Overview
A Phase 2 trial of remestemcel-L-rknd in myocardial infarction (MI), sponsored by Mesoblast Ltd. Started Mar 2009; status: completed.
02
Drugs
remestemcel-L-rknd
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT00877903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00877903.